UBS Group’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.22M | Buy |
|
|||||
|
2025
Q1 | $1.08M | Sell |
|
|||||
|
2024
Q4 | $1.76M | Buy |
|
|||||
|
2024
Q3 | $125K | Buy |
|
|||||
|
2024
Q2 | $67K | Buy |
|
|||||
|
2024
Q1 | $229 | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $22K | Buy |
|
|||||
|
2022
Q4 | $11.2K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $49K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $4K | Hold |
|
|||||
|
2021
Q1 | $4K | Sell |
|
|||||
|
2020
Q4 | $47K | Buy |
|
|||||
|
2020
Q3 | $5K | Buy |
|